https://doi.org/10.1038/s41467-020-15548-7
J
Jennifer M. Rosenbluth
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
2.7K
Citations
19
h-index
21
i10-index
Jennifer M. Rosenbluth is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Breast Cancer Treatment Studies & CAR-T cell therapy research. The author has an h-index of 19, co-authored 84 publications.
ORCID: 0000-0003-1314-6976Papers by this author
worksOrganoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages
2020 · Nature Communications · 265 citations
p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network
2016 · Cell Reports · 143 citations
https://doi.org/10.1016/j.celrep.2016.02.035
Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ
2025 · JAMA Oncology · 14 citations
https://doi.org/10.1001/jamaoncol.2024.5927
T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation
2024 · Cancer Immunology Research · 9 citations
https://doi.org/10.1158/2326-6066.cir-24-0416
Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ
2024 · npj Breast Cancer · 3 citations
https://doi.org/10.1038/s41523-024-00677-9
DISCOVERY AND CHARACTERIZATION OF THE MTOR-P73 SIGNALING AXIS IN HUMAN CANCER By
2009 · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat